Actively Recruiting

Phase 2
Age: 18Years - 50Years
All Genders
NCT07470359

Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection.

Led by Lahore General Hospital · Updated on 2026-03-13

60

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective RCT investigates if a single 4 ml intra-articular PRP injection improves knee function after ACL reconstruction using peroneus longus autograft. In Pakistan's resource-limited context, 88 patients (18-50 years) with isolated ACL tears receive either PRP or saline during surgery, then randomized equally. KOOS4 scores compared at 3, 6, and 12 months via ANCOVA (adjusted baseline, α=0.05). Positive results could establish affordable enhancement for recovery and guide practice in similar settings.

CONDITIONS

Official Title

Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection.

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 50 years
  • Diagnosis of a primary, complete ACL tear requiring reconstruction
  • Willingness to undergo arthroscopic ACL reconstruction with peroneus longus autograft
  • Active individuals participating in sports or regular physical activity
  • Willingness to provide informed consent and follow study protocol, including follow-up visits and rehabilitation
  • Ability to understand and complete study questionnaires
Not Eligible

You will not qualify if you...

  • Previous knee surgery on the affected limb
  • Additional ligament injuries requiring reconstruction (e.g., PCL, MCL, LCL Grade III)
  • Significant cartilage damage (Outerbridge grade > 2)
  • Pre-existing knee osteoarthritis (Kellgren-Lawrence grade > 2)
  • Systemic inflammatory diseases (e.g., rheumatoid arthritis)
  • Bleeding disorders or use of anticoagulant medications
  • Corticosteroid injection into the knee within 6 weeks before surgery
  • Pregnancy or breastfeeding
  • Inability to follow rehabilitation protocol
  • Infection or history of infection in the affected knee
  • Previous ACL injury on the opposite knee

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lahore General Hospital

Lahore, Punjab Province, Pakistan, 54000

Actively Recruiting

Loading map...

Research Team

H

Hafiz Sohail Ahmad, Dr

CONTACT

A

Abdul Subhan Zahid, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here